Abstract:Cellular senescence is a diverse phenotype characterised by permanent cell cycle arrest and an inflammatory senescence associated secretory phenotype (SASP). Typically, senescent cells are removed by the immune system. This process becomes dysregulated with age and senescent cells accumulate leading to chronic inflammatory signalling. Identifying senescent cells is challenging due to the heterogeneity of senescence, and senotherapy often requires a combinatorial approach. Here we have taken an integrative approach to investigate senescence development at the transcriptomic and protein level. We systematically collected 119 transcriptomic datasets related to human fibroblasts, forming an online database describing the relevant study variables which users can filter to select variables and genes of interest. Our own analysis of the database identified 28 genes significantly up- or downregulated across four senescence types (DNA-damage induced senescence (DDIS), oncogene-induced senescence (OIS), replicative senescence, and bystander induced senescence); 14 genes consistently downregulated, 10 genes consistently upregulated and 4 genes regulation dependent on senescence type. We also found gene expression patterns of conventional senescence markers were highly specific and reliable for different senescence inducers, cell lines, and timepoints. Conclusions of existing studies based on single datasets were supported such as differences in p53 and inflammatory signals between DDIS and OIS. However, contrary to some early observations, both p16 and p21 mRNA levels appeared to rise quickly, depending on senescence type, and persist for at least 8-11 days. Additionally, little evidence was found to support an initial TGF-β-centric SASP. To support our transcriptomic analysis, we computationally modelled temporal protein changes of core senescence proteins in DDIS and OIS, as well as performed knockdown interventions. We conclude that while universal biomarkers of senescence are difficult to identify, conventional senescence markers follow predictable profiles and construction of a workflow for studying senescence could lead to more reproducible data and understanding of senescence heterogeneity.

Modelling the spatiotemporal dynamics of senescent cells in wound healing, chronic wounds, and fibrosis

A chronic wound model to investigate skin cellular senescence

Transfer learning in a biomaterial fibrosis model identifies in vivo senescence heterogeneity and contributions to vascularization and matrix production across species and diverse pathologies

Systematic transcriptomic analysis and temporal modelling of the senescent human fibroblast

Cellular senescence and wound healing in aged and diabetic skin

Clinicopathological and cellular senescence biomarkers in chronic stalled wounds

Assessing Animal Models to Study Impaired and Chronic Wounds

Systematic transcriptomic analysis and temporal modelling of human fibroblast senescence

Modulation of fracture healing by the transient accumulation of senescent cells

Cellular senescence: from physiology to pathology

Cellular Senescence: Mechanisms, Morphology, and Mouse Models

Cellular senescence: the good, the bad and the unknown

Targeting Senescent Cells in Fibrosis: Pathology, Paradox, and Practical Considerations

Modeling Wound Chronicity In Vivo: The Translational Challenge to Capture the Complexity of Chronic Wounds

Senescence in a cell culture model for burn wounds

Emerging role of cellular senescence in the pathogenesis of oral submucous fibrosis and its malignant transformation

Senescent cells: SASPected drivers of age-related pathologies

Exploring the Communication of the SASP: Dynamic, Interactive, and Adaptive Effects on the Microenvironment

Mapping cellular senescence networks in human diabetic foot ulcers

Senescence and tissue fibrosis: opportunities for therapeutic targeting

Understanding the regulation of chronic wounds by tissue inhibitors of matrix metalloproteinases through mathematical modelling